Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-09-02 4:01 pm Purchase | 2026-08-26 | 13G | JATT III Acquisition Corp JTTT | Deep Track Capital, LP | 450,000 5.830% | 450,000 (New Position) | Filing History |
| 2026-08-14 08:36 am Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 7,736,455 7.450% | 1,391,211 (+21.93%) | Filing History |
| 2026-08-14 08:34 am Purchase | 2026-06-30 | 13G | X4 PHARMACEUTICALS INC XFOR | Deep Track Capital, LP | 8,040,894 8.330% | 5,673,899 (+239.71%) | Filing History |
| 2026-08-14 08:32 am Sale | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital, LP | 3,592,740 3.250% | -1,824,920 (-33.68%) | Filing History |
| 2026-08-14 08:32 am Sale | 2026-06-30 | 13G | PERSONALIS INC PSNL | Deep Track Capital, LP | 4,000,000 3.820% | -1,760,627 (-30.56%) | Filing History |
| 2026-08-14 08:28 am Purchase | 2026-06-30 | 13G | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | Deep Track Capital, LP | 7,999,025 9.740% | 3,388,954 (+73.51%) | Filing History |
| 2026-08-14 08:27 am Sale | 2026-06-30 | 13G | MBX BIOSCIENCES INC MBX | Deep Track Capital, LP | 1,732,569 3.640% | -456,023 (-20.84%) | Filing History |
| 2026-08-14 08:27 am Sale | 2026-06-30 | 13G | IMMUNOVANT INC IMVT | Deep Track Capital, LP | 9,341,151 4.550% | -158,849 (-1.67%) | Filing History |
| 2026-08-14 08:26 am Sale | 2026-06-30 | 13G | ENANTA PHARMACEUTICALS INC ENTA | Deep Track Capital, LP | 1,444,167 4.970% | -512,700 (-26.20%) | Filing History |
| 2026-08-14 08:25 am Sale | 2026-06-30 | 13G | ENGENE THERAPEUTICS INC ENGN | Deep Track Capital, LP | 0 0.000% | -4,317,332 (Position Closed) | Filing History |
| 2026-08-14 08:24 am Purchase | 2026-06-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 3,610,000 6.870% | 554,973 (+18.17%) | Filing History |
| 2026-08-13 4:05 pm Purchase | 2026-08-07 | 13G | LATIGO BIOTHERAPEUTICS INC LTGO | Deep Track Capital, LP | 4,446,656 7.030% | 4,446,656 (New Position) | Filing History |
| 2026-08-12 4:02 pm Purchase | 2026-08-05 | 13G | ATTOVIA THERAPEUTIS INC ATTO | Deep Track Capital, LP | 3,207,138 7.450% | 3,207,138 (New Position) | Filing History |
| 2026-08-11 4:03 pm Purchase | 2026-08-04 | 13G | OBSIDIAN THERAPEUTICS INC OBX | Deep Track Capital, LP | 3,315,605 5.370% | 3,315,605 (New Position) | Filing History |
| 2026-06-17 4:00 pm Purchase | 2026-06-10 | 13G | SHATTUCK LABS INC STTK | Deep Track Capital, LP | 5,000,033 5.170% | 5,000,033 (New Position) | Filing History |
| 2026-05-29 4:37 pm Purchase | 2026-05-22 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Deep Track Capital, LP | 3,055,027 5.810% | 3,055,027 (New Position) | Filing History |
| 2026-05-15 09:14 am Sale | 2026-03-31 | 13G | DEFINIUM THERAPEUTICS INC DFTX | Deep Track Capital, LP | 3,000,000 3.010% | -2,676,540 (-47.15%) | Filing History |
| 2026-05-15 08:46 am Purchase | 2026-03-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Deep Track Capital, LP | 3,600,000 8.460% | 600,000 (+20.00%) | Filing History |
| 2026-05-15 08:46 am Purchase | 2026-03-31 | 13G | OCULAR THERAPEUTIX INC OCUL | Deep Track Capital, LP | 20,850,000 9.530% | 9,615,868 (+85.60%) | Filing History |
| 2026-05-15 08:45 am Purchase | 2026-03-31 | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital, LP | 6,345,244 6.170% | 845,244 (+15.37%) | Filing History |